Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.08%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.23%ZECUSDT+2.21%XMRUSDT-0.09%DOGEUSD+69.80%LINKUSD+2.45%XLMUSD-0.44%BCHUSDT-0.15%LTCUSD+68.40%UNIUSD-0.57%TONUSD+79.92%SUIUSD+1.82%HBARUSDT-0.07%TAOUSDT+2.85%AAVEUSD+1.52%ONDOUSDT+1.26%DOTUSDT+1.46%ICPUSDT+2.21%WLDUSDT+2.88%ARBUSDT+2.88%ATOMUSDT+1.90%INJUSDT+5.70%STXUSDT+4.18%PYTHUSDT+3.71%TIAUSDT+3.05%FETUSDT-0.13%SEIUSDT+0.59%JUPUSDT+2.33%GRTUSDT+0.86%OPUSDT+2.97%IOTAUSDT+2.14%POLUSDT+0.15%WIFUSDT+2.36%AXSUSDT+0.17%EOSUSDT+0.99%IMXUSDT+0.09%FARTCOINUSDT+1.61%GALAUSDT+3.50%DYDXUSDT+0.84%ORDIUSDT+2.72%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.08%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.23%ZECUSDT+2.21%XMRUSDT-0.09%DOGEUSD+69.80%LINKUSD+2.45%XLMUSD-0.44%BCHUSDT-0.15%LTCUSD+68.40%UNIUSD-0.57%TONUSD+79.92%SUIUSD+1.82%HBARUSDT-0.07%TAOUSDT+2.85%AAVEUSD+1.52%ONDOUSDT+1.26%DOTUSDT+1.46%ICPUSDT+2.21%WLDUSDT+2.88%ARBUSDT+2.88%ATOMUSDT+1.90%INJUSDT+5.70%STXUSDT+4.18%PYTHUSDT+3.71%TIAUSDT+3.05%FETUSDT-0.13%SEIUSDT+0.59%JUPUSDT+2.33%GRTUSDT+0.86%OPUSDT+2.97%IOTAUSDT+2.14%POLUSDT+0.15%WIFUSDT+2.36%AXSUSDT+0.17%EOSUSDT+0.99%IMXUSDT+0.09%FARTCOINUSDT+1.61%GALAUSDT+3.50%DYDXUSDT+0.84%ORDIUSDT+2.72%NOTUSDT+1.19%RONINUSDT+1.91%
AP

ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ • Healthcare

$68.55
-$0.57 (-0.8%)
Market closed

Last close at November 20, 2026 at 21:00 UTC

Open$68.96
Day Range$68.28 - $70.2
Avg. Volume (3M)486.7K
Market Cap$1.5B
P/E Ratio13.2
52 Week Range
$67.14$87.76

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$290.7M100%
Gross Profitminus cost of goods$179.2M62%
Operating Incomeminus R&D and overhead$52.3M18%
Net Incomeminus taxes and the rest$35.1M12%

In plain terms: out of every $100 in revenue, ANI Pharmaceuticals, Inc. keeps $12 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1B
Net Income (TTM)
$116.8M
EPS (TTM)
$5.18
ROA (TTM)
7.45%
Current Ratio
2.75
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+60.2%Q2 2026$2.05
+8.3%Q3 2026$2.21
+23.9%Q4 2026$2.7

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +23.9%

ANI Pharmaceuticals beat expectations on both the top and bottom line in the third fiscal quarter of 2026, reported November 5, 2026, with revenue of $290.8 million topping the $280.6 million estimate (+3.6%) as revenue rose ~28% from about $227.8 million a year ago, reflecting its mix of specialty and generic medicines. Adjusted EPS of $2.70 topped the $2.18 estimate (+23.9%) and was up from $2.04 a year ago, alongside net income that climbed ~46% to roughly $35.1 million from about $24.1 million. Profitability remained elevated, with gross margin at roughly 62% and operating margin near 18%, while operating income came in at about $52.4 million. The quarter also generated about $83.8 million of operating cash flow, and the company repurchased roughly $7.9 million of stock. For the next period, consensus calls for EPS of $2.80 on revenue of $319.5 million.

View full earnings history

About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. develops and markets specialty and generic medicines and manufactures a broad range of dose forms, from injectables and softgel capsules to oral solid doses, semi-solids, liquids, topicals, controlled substances, and potent products. Listed on NASDAQ as ANIP, the company operates in pharmaceuticals and generated $883.4 million of revenue in FY2025.

Name
ANI Pharmaceuticals, Inc.
CEO
Nikhil Lalwani
Industry
Healthcare
Year Founded
2001
Employees
970

Today's Snapshot

AI-generated

ANIP closed 0.8% below yesterday's close, while its sector was flat. Shares changed hands at about two-fifths of its usual level.

Trading Volume

Below 10d avg (526.1K)

217.9K

vs S&P 500 Today

Outperforming Market

+2.65%

Updated: November 20, 2026 at 21:25 UTC

Technical Indicators

0 Buy2 Neutral6 Sell
ANIP is showing clear downside bias as the stock trades below its short- and long-term moving averages, with the 200-day sitting notably higher and the price under recent pivots. Momentum readings are mixed but lean negative, with MACD and CCI signaling weakness while short-momentum measures show limited support, and on-balance volume is negative which confirms distribution. Volatility is moderate relative to price, and the ADX indicates a weak directional trend rather than a decisive reversal. Technical takeaway: Strong Sell — price remains beneath key moving averages with weak momentum and deteriorating volume.
All signals
  • EMA (5 indicators)$70.15 - $76.27
    Sell
  • RSI (14)41.30
    Neutral
  • Stochastic %K (14, 3, 3)29.08
    Neutral
  • MACD Level (12, 26)-0.71
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.